IL2 and acute myeloid leukemia: In accordance with the results obtained with K562 cells, the capacity to produce IFN-γ was strongly diminished in untreated AML patients, normalized in patients after chemotherapy, and maintained or slightly further increased in HDC plus IL-2 treated patients.